These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Results and prognostic factors of hypofractionated stereotactic radiation therapy for primary or metastatic lung cancer. Kim H; Ahn YC; Park HC; Lim DH; Nam H J Thorac Oncol; 2010 Apr; 5(4):526-32. PubMed ID: 20104193 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. Grieco CA; Simon CJ; Mayo-Smith WW; DiPetrillo TA; Ready NE; Dupuy DE J Vasc Interv Radiol; 2006 Jul; 17(7):1117-24. PubMed ID: 16868164 [TBL] [Abstract][Full Text] [Related]
12. CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial. Peters N; Wieners G; Pech M; Hengst S; Rühl R; Streitparth F; Lopez Hänninen E; Felix R; Wust P; Ricke J Strahlenther Onkol; 2008 Jun; 184(6):296-301. PubMed ID: 18535804 [TBL] [Abstract][Full Text] [Related]
13. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy. Kolotas C; Tselis N; Sommerlad M; Röddiger S; Schnabel T; Baltas D; Kalogera-Fountzila A; Fountzilas G; Zamboglou N Strahlenther Onkol; 2007 Feb; 183(2):69-75. PubMed ID: 17294110 [TBL] [Abstract][Full Text] [Related]
14. Long-term clinical experience of high-dose ablative lung radiotherapy: high pre-treatment [18F]fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome. Lee DS; Kim YS; Yoo IeR; Kang YN; Kim SJ; Oh JK; Kim YK; Wang YP; Park JG; Kang JH; Han DH; Ahn MI; Lee KY Lung Cancer; 2013 May; 80(2):172-8. PubMed ID: 23489556 [TBL] [Abstract][Full Text] [Related]
17. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362 [TBL] [Abstract][Full Text] [Related]
18. A clinical study of shrinking field radiation therapy based on (18)F-FDG PET/CT for stage III non-small cell lung cancer. Ding X; Li H; Wang Z; Huang W; Li B; Zang R; Sun H; Yi Y Technol Cancer Res Treat; 2013 Jun; 12(3):251-7. PubMed ID: 23289475 [TBL] [Abstract][Full Text] [Related]
19. Hypofractionated accelerated CT-guided interstitial ¹⁹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer. Tselis N; Ratka M; Vogt HG; Kolotas C; Baghi M; Baltas D; Fountzilas G; Georgoulias V; Ackermann H; Zamboglou N Radiother Oncol; 2011 Jan; 98(1):57-62. PubMed ID: 21129799 [TBL] [Abstract][Full Text] [Related]
20. Interstitial Brachytherapy for the Treatment of Locally Recurrent Anorectal Cancer. Bishop AJ; Gupta S; Cunningham MG; Tao R; Berner PA; Korpela SG; Ibbott GS; Lawyer AA; Crane CH Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S596-602. PubMed ID: 25905584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]